Matrix Metalloproteinase Inhibitors as Prospective Agents for the Prevention and Treatment of Cardiovascular and Neoplastic Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|6|4|289-316

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.6, Iss.4, 2006-02, pp. : 289-316

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of DNA Methyltransferase Inhibitors for the Treatment of Neoplastic Diseases

By  

Current Medicinal Chemistry, Vol. 16, Iss. 17, 2009-06 ,pp. : 2075-2085

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix Metalloproteinase Knockout Studies and the Potential Use of Matrix Metalloproteinase Inhibitors in the Rheumatic Diseases

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 3, 2005-06 ,pp. : 363-375

Bentham Science Publishers

Access to resources Recommend Favorite

Nutraceuticals - An Emerging Era in the Treatment and Prevention of Cardiovascular Diseases

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 1, 2006-02 ,pp. : 15-23

Bentham Science Publishers

Access to resources Recommend Favorite

Polyphenols: Potential Use in the Prevention and Treatment of Cardiovascular Diseases

By  

Current Pharmaceutical Design, Vol. 24, Iss. 2, 2018-04 ,pp. : 239-258

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix metalloproteinase inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1213-1216

Informa Healthcare

Access to resources Recommend Favorite